<DOC>
	<DOCNO>NCT01220167</DOCNO>
	<brief_summary>The purpose study compare dose effect water single dose bioavailability Ondansetron ODFS 8mg ( MonoSol Rx , USA ) administer without water Zofran ODT® 8mg administer without water healthy male female adult , human study participant fast condition . - To monitor clinical status , adverse event laboratory investigation , assess relative safety tolerance study drug formulation fast condition . - To estimate intra-subject coefficient variation ( CV ) .</brief_summary>
	<brief_title>Three-way Crossover Comparative Water-effect Bioavailability Compare Ondansetron ODFS 8mg With Without Water With Zofran ODT 8mg Without Water 18 Healthy Participants Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Inclusion Criteria The criterion inclusion : Study volunteer provide write informed consent . Study volunteer must healthy adult within 1845 year age ( inclusive ) . Study volunteer Body mass index ≥ 18.5 kg/m2 ≤ 25 kg/m2 , body weight less 50 kg . Study volunteer systolic blood pressure upper limit le 140 mmHg low limit equal 90 mm Hg . Similarly diastolic blood pressure upper limit le 90 mm Hg low limit equal 60 mmHg . Study volunteer must normal health determine medical history physical examination perform within 15 day prior dose period 1 . Study volunteer normal ECG , chest Xray vital sign . Availability study volunteer entire study period willingness adhere protocol requirement evidence write informed consent . If study volunteer female child bear potential must practice acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . full menopause , i.e. , postmenopausal least 1 year . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform study volunteer ) Each female study volunteer give urine pregnancy test screening , checkin period1 , period2 period 3 post study . Exclusion Criteria The participant exclude base follow criterion : Study volunteer incapable understanding informed consent . Study volunteer history hypersensitivity idiosyncratic reaction study drug relate drug . Study volunteer evidence impairment renal , hepatic , cardiac , lung gastrointestinal function standard laboratory , image monitoring procedure . Study volunteer history tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study . Study volunteer smoke regularly ten cigarette daily difficulty abstain smoke duration study period ( least 48 hour dose period prohibit throughout stay CPU last PK sample collect period ) . Study volunteer take counter prescribed medication , include enzyme modifying drug ( Ref : www.medicine.iupui.edu/Flockhart/clinlist.htm 14k ) systemic medication within past 30 day prior dose first period . Study volunteer history psychiatric illness , may impair ability provide write , informed consent full participation cooperation study protocol . Study volunteer history alcohol substance abuse within last 5 year . Study volunteer clinically significant abnormal value laboratory parameter . Study volunteer participate clinical investigation use experimental drug bleed 350 mL past 3 month . Study volunteer unable likely noncompliant protocol requirement restriction . Study volunteer study drug contraindicate medical reason Study volunteer intolerant venipuncture . Female volunteer use implant injected hormonal contraceptive anytime 6 month prior study use hormonal contraceptive within 14 day dose . Female volunteer demonstrate positive pregnancy screen . Each female study volunteer screen pregnancy screening , checkin study period . Study volunteer positive inconclusive result withdrawn study . Female volunteer currently breast feed . Female study volunteer pregnant , breastfeed likely become pregnant study allow participate . Female study volunteer child bear potential must either abstain sexual intercourse use reliable barrier method ( e.g . condom , IUD ) contraception course study ( first dose last blood collection ) allow participate . Study volunteer positive urine screen drug abuse time admission checkin period exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>